Contract 75A50123F61002
Texas Biomedical Research Institute · Department Of Health And Human Services · September 27, 2023
Texas Biomedical Research Institute was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 27, 2023 for $134.52 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in San Antonio, TX. This is a task or delivery order issued under parent IDIQ 75A50122D00020. The contract has been modified 15 times since the base award It uses cost-plus contract pricing. The most recent modification was on December 21, 2025.
Contract details
- PIID
- 75A50123F61002
- Parent IDIQ
- 75A50122D00020
- Award type
- Delivery Order
- Pricing
- Cost Plus Fixed Fee
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Experimental Development
- Place of performance
- San Antonio, TX
- First action
- September 27, 2023
- Latest action
- December 21, 2025
Description
BIO-AMT-2303: GLP NATURAL HISTORY STUDIES IN NHP MODELS OF FILOVIRUS INFECTION
Modification timeline
-
December 21, 2025Mod P00005 · Supplemental Agreement For Work Within Scope$6.69M
-
December 2, 2025Mod P00004 · Other Administrative ActionTESTING SERVICES TO SUPPORT TRANSLATIONAL DEVELOPMENT OF NEXT-GENERATION BOTULISM THERAPEUTIC PRODUCTS$5.40M
-
November 19, 2025Mod P00003 · Other Administrative ActionOT TASK ORDER 2$120.25M
-
September 25, 2025Mod P00004 · Exercise An Option$6.69M
-
June 26, 2025Mod P00003 · Supplemental Agreement For Work Within Scope$2.34M
-
September 24, 2024Mod P00002 · Supplemental Agreement For Work Within ScopeOT TASK ORDER 2$120.25M
-
August 30, 2024Mod P00004 · Supplemental Agreement For Work Within ScopeTASK ORDER 2: PICK-UP, STORE, SCAN AND DESTROY DOCUMENTS FOR BARDA CMA AND ASPR$78.5K
-
August 7, 2024Mod P00005 · Other Administrative ActionREPURPOSING OF A FERRIC IRON-CONTAINING HEME B COMPLEX (PANHEMATIN) AND A SULFANE SULFUR-LINKED DITHIOCARBAMATE (DISULFIRAM) AS POTENTIAL MCMS AGAINST KNOCKDOWN AGENTS$1.72M
-
June 27, 2024Mod P00003 · Supplemental Agreement For Work Within ScopeTASK ORDER 2: PICK-UP, STORE, SCAN AND DESTROY DOCUMENTS FOR BARDA CMA AND ASPR$78.5K
-
June 26, 2024Mod P00004 · Other Administrative ActionREPURPOSING OF A FERRIC IRON-CONTAINING HEME B COMPLEX (PANHEMATIN) AND A SULFANE SULFUR-LINKED DITHIOCARBAMATE (DISULFIRAM) AS POTENTIAL MCMS AGAINST KNOCKDOWN AGENTS$1.72M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50123F61002?
Contract 75A50123F61002 is a federal contract awarded to Texas Biomedical Research Institute by Department Of Health And Human Services on September 27, 2023 for $134.52 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 15 times since the base award.
Who won contract 75A50123F61002?
Texas Biomedical Research Institute won contract 75A50123F61002 from Department Of Health And Human Services.
How much is contract 75A50123F61002 worth?
Contract 75A50123F61002 has obligated $134.52 million to date.